ZMZahra Noorani Mejareh

Zahra Noorani Mejareh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zahra Noorani Mejareh has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The global Prevalence of Depression among Health Workers during the COVID-19 pandemic: a Systematic review and Meta-analysis

    by Sepide Rezaei, Zahra Hoseinipalangi, Sima Rafiei, Yasamin Dolati, Hossein Hosseinifard, Mahsa Tohidi Asl, Zahra Noorani Mejareh, Sama Deylami, Bahare Abdollahi, Mohadeseh Fadavi Ardakani, et al.


  • Hemodialysis and peritoneal dialysis—health-related quality of life: systematic review plus meta-analysis

    by Samira Raoofi, Fatemeh Pashazadeh Kan, Sima Rafiei, Zahra Hoseinipalangi, Sepide Rezaei, Saba Ahmadi, Maryam Masoumi, Zahra Noorani Mejareh, Mahshid Roohravan Benis, Alireza Sharifi, et al.

    Background Patients with end-stage renal disease undergoing haemodialysis experience a variety of stressors leading to decreased level of quality of life (QoL). Thus, in this study, we aimed to review the current literature and identify factors affecting the health-related QoL (HRQoL) in these patients. Methods A total of 147 studies were extracted from databases of Web of Science, PubMed, Scopus, Google Scholar, and Embase published between January 2000 and December 2020. Data were analysed using R software and results were reported with reference to Preferred Reporting Items for Systematic Reviews and Meta-Analyses standards. Results A total of 623 728 patients undergoing dialysis participated in 147 studies in which QoL was assessed by means of two valid questionnaires, including Short-Form 36 (SF-36) and Kidney Disease Quality of Life (KDQOL)-short form V.1.3. Total HRQoL score for patients undergoing dialysis measured by KDQOL was 64.25 (95% CI 55.67 to 72.82). Based on SF-36, the mean score of mental health items was higher than the mean score of physical health condition. Furthermore, meta-regression based on the geographical place of residence revealed that the highest QoL in patients was observed in Japan, 66.96 (95% CI 63.65 to 70.28) and Brazil, 58.03 (95% CI 53.45 to 62.6). Conclusion Studies conducted on HRQoL among patients undergoing dialysis recommend useful strategies to clinicians, letting them assess patients’ QoL in terms of a wide range of physical, mental and environmental aspects.


  • Open Access

    Effects of Immune System-Related Medications on COVID-19 Outcome in a Cohort of Iranian Patients: Preliminary Report of a Data Mining Study

    by Ehsan Bitaraf, Seyyed Amir Yasin Ahmadi, Alireza Gandomi-Mohammadabadi, Zahra Noorani Mejareh, Bahare Abdollahi, Javad Balasi, Farzan Moodi, Nima Hemmati, Ali Kabir

    Background. Regulation of the immune system is critical for fighting against viral infections. Both suppression and hyperactivity of the immune system result in failure of treatment. The present study was designed to show the effects of immune system-related medications on mortality and length of stay (LOS) in a cohort of Iranian patients with coronavirus disease 2019 (COVID-19). Methods. A data mining study was performed on 6417 cases of COVID-19 covered by 17 educational hospitals of Iran University of Medical Sciences, Tehran. Association of a researcher-designed drug list with death and LOS was studied. For death outcome, logistic regression was used reporting odds ratio (OR) with 95% confidence interval (CI). For LOS, right censored Poisson regression was used reporting incidence rate ratio (IRR) with 95% CI. Results. Among the corticosteroids, prednisolone was a risk factor on death ( , ). This association was increased after adjustment of age interactions ( , ) and was removed after adjustment of ICU admission interactions ( , ). Hydroxychloroquine showed a protecting effect on death ( , ); however, this association was removed after adjustment of age interactions ( , ). Among the antivirals, oseltamivir showed a protecting effect on death ( <g...